Titre:
  • Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.
Auteur:Chia, Stephen; Gradishar, William J.; Mauriac, L; Bines, Jose; Amant, F.; Federico, Miriam; Fein, Luis; Romieu, Gilles; Buzdar, Aman; Robertson, John F R; Brufsky, Adam; Possinger, Kurt; Rennie, Pamela; Sapunar, Francisco; Lowe, Elizabeth; Piccart-Gebhart, Martine
Informations sur la publication:Journal of clinical oncology, 26, 10, page (1664-1670)
Statut de publication:Publié, 2008-04
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Androstadienes -- therapeutic use
Antineoplastic Agents -- therapeutic use
Aromatase Inhibitors -- therapeutic use
Breast Neoplasms -- drug therapy
Breast Neoplasms -- metabolism
Breast Neoplasms -- mortality
Double-Blind Method
Estradiol -- analogs & derivatives
Estradiol -- therapeutic use
Female
Humans
Kaplan-Meiers Estimate
Neoplasm Recurrence, Local -- drug therapy
Placebos
Postmenopause
Quality of Life
Receptors, Estrogen -- metabolism
Note générale:Clinical Trial, Phase III
Journal Article
Multicenter Study
Randomized Controlled Trial
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2007.13.5822
info:pii/JCO.2007.13.5822
info:pmid/18316794